Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium in Amyotrophic Lateral Sclerosis (LISLA)
NCT00925847Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2009
- Primary completion
- Apr 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium in amyotrophic lateral sclerosis (ALS), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2009; status: completed.
02
Drugs
lithium
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00925847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925847.